Summary
The New York State Contract Reporter (NYSCR) lists the discretionary procurement solicitation QALSODY (Tofersen) 100ml/15ml SDV (CR# 2136841) for SUNY Stony Brook University Hospital in the Medical & Health Care category, with a procurement value between $50,000 and $125,000. The solicitation seeks to purchase QALSODY (tofersen), a 100 mg/15 mL (6.7 mg/mL) single-dose vial drug used to treat adults with amyotrophic lateral sclerosis (ALS) who have a mutation in the SOD1 gene. The Stony Brook purchasing website directs vendors to NYSCR (nyscr.ny.gov) as the official source for all Stony Brook University and Stony Brook Medicine procurement opportunities.